Medrad has acquired 1 company of its own. It has also divested 1 asset.
Medrad’s largest acquisition to date was in 2008, when it acquired Possis Medical for $361M. It’s largest disclosed sale occurred in 2011, when it sold Pathway Medical Technologies to Bayer HealthCare AG for $99M. Medrad has acquired in 1 US state. The Company’s most targeted sectors include medical products (100%).
Join Mergr and gain access to Medrad’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1